MedPath

Observational Study of Sacral Nerve Function After Sacral Tumor Resection

Not yet recruiting
Conditions
Sacral Tumors
Registration Number
NCT07105644
Lead Sponsor
Shanghai Changzheng Hospital
Brief Summary

The goal of this observational study is to evaluate the long-term effects of sacral tumor resection on sacral nerve function in patients with primary sacral tumors, including chordomas and chondrosarcomas. The study will primarily focus on understanding how the level of sacral resection impacts postoperative motor, bowel, bladder, and sexual functions. The main questions it aims to answer are:

How does the level of sacral resection influence bowel and bladder function at 12 months post-surgery? What is the role of preserving the sacral nerve root in maintaining motor function and sexual function? Participants will include patients who have undergone sacral tumor resection and will be followed for 12 months post-surgery. They will provide data on their bowel, bladder, and motor functions, as well as sexual function, through clinical evaluations and standardized questionnaires.

Participants will:

Complete surveys on bowel, bladder, and motor function at baseline and at 3, 6, and 12 months after surgery Undergo clinical assessments, including anorectal manometry, post-void residual urine volume measurements, and sensory evaluations Be evaluated for changes in sexual function using standardized surveys like IIEF (for males) and FSFI (for females)

Detailed Description

This observational study is designed to assess the long-term impact of sacral tumor resection on sacral nerve function in patients diagnosed with primary sacral tumors, such as chordomas and chondrosarcomas. The objective is to determine the relationship between the level of sacral resection and the preservation of bowel, bladder, motor, and sexual functions post-surgery. The study will track functional recovery over 12 months, focusing on how different resection levels affect these outcomes.

The study will include patients who undergo sacral tumor resection with varying degrees of nerve root sacrifice. Participants will be categorized based on the extent of resection: those who undergo a low sacrectomy and those who undergo a high sacrectomy.

The primary research questions are:

How does the level of sacral resection (low, middle, high, or total) impact functional outcomes such as bowel, bladder, motor, and sexual function at 12 months post-surgery?

How does the preservation of the sacral nerve root affect functional recovery compared to the sacrifice of this nerve root?

To address these questions, participants will complete a series of standardized questionnaires at baseline, 3 months, 6 months, and 12 months after surgery to assess:

Bowel Function: Evaluated using anorectal manometry and the Cleveland Constipation Score and Wexner Incontinence Score.

Bladder Function: Assessed through ICIQ-SF (bladder function), Saito grading, and urodynamic tests (e.g., maximum urinary flow, post-void residual urine).

Motor Function: Evaluated through Frankel scores and mobility assessments.

Sexual Function: Measured using the IIEF for males and the FSFI for females.

This study will provide important data on the functional outcomes of sacral tumor resection, helping to guide clinical decisions on surgical techniques and post-surgical management to optimize patient recovery and quality of life.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria

Age between 12 and 80 years Confirmed diagnosis of sacral tumor (either a primary bone tumor or a metastatic tumor from another solid malignancy) Able to understand the study requirements and provide written informed consent

Exclusion Criteria

Poor general condition rendering the patient unable to tolerate surgery History of diseases or surgeries affecting bowel or bladder function Missing intraoperative data regarding sacral resection level or nerve root sacrifice Pregnant or currently breastfeeding Missing critical follow-up data or lost to follow-up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bladder Function Score at 12 Months Post-Surgery12 months post-surgery: Bladder function will be assessed during a comprehensive follow-up visit at 12 months after the surgery.

The primary outcome measure will assess bladder function 12 months after sacral tumor resection surgery. Based on the Biagini et al. method and supported by literature such as Huang et al the bladder function scoring system commonly used in sacrectomy outcome studies includes the following components:

0-Normal

1. Feels stimulus to micturate and has limited continence at varying times and quantities of urine and/or has increasing postmicturition vesical residual and/or urinary loss in conditions of stress

2. Does not feel stimulus to micturate and/or is completely incontinent

Secondary Outcome Measures
NameTimeMethod
Rectal Function Score at 12 Months Post-Surgery12 months post-surgery: Rectal function will be assessed during a follow-up visit at 12 months after the surgery.

The secondary outcome measure will assess rectal function 12 months after sacral tumor resection surgery. Based on the Biagini et al. method and supported by literature such as Huang et al the Rectal function scoring system commonly used in sacrectomy outcome studies includes the following components:

0-Normal

1. Feels stimulus to defecate and is incontinent when feces are soft or under stress

2. Does not feel stimulus to defecate and/or is completely incontinent

Trial Locations

Locations (1)

Changzheng Hospital

🇨🇳

Shanghai, Shanghai, China

Changzheng Hospital
🇨🇳Shanghai, Shanghai, China
pengru Wang, Doctor
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.